Investigation of the impact of CRIM1 on breast cancer prognosis using Kaplan-Meier and PrognoScan analyses revealed that reduced CRIM1 levels correlated with poorer RFS, OS, DSS, DFS, and DMFS. Here, CRIM1 is linked to breast cancer.